Concepedia

Vibha Oza

VO

Statistics

Publications

13

Citations

1.1K

H-Index

13

Active since

1995

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Scripps Research Institute

AstraZeneca (Sweden)

Vibha Oza is an author at AstraZeneca (United States) specializing in drug discovery, medicinal chemistry, and pharmacology.

Publications per year

1995–2015

13

Publications

13

Rational design of potent human transthyretin amyloid disease inhibitors.

James C. Sacchettini, Thomas Klabunde, H. Michael Petrassi et al. · Nature Structural Biology · 2000 · 370 citations

, , +12

Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid

Paul W. Baures, Vibha Oza, Scott Peterson et al. · Bioorganic & Medicinal Chemistry · 1999 · 135 citations

, , +16

Synthesis, Structure, and Activity of Diclofenac Analogues as Transthyretin Amyloid Fibril Formation Inhibitors

Vibha Oza, Craig Smith, Prakash Raman et al. · Journal of Medicinal Chemistry · 2001 · 132 citations · Full text

, , +16

Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)

Edward J. Hennessy, Ammar Adam, Brian Aquila et al. · Journal of Medicinal Chemistry · 2013 · 115 citations · Full text

, , +17

Synthesis and evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors

Vibha Oza, H. Michael Petrassi, Hans E. Purkey et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 78 citations

, , +10

1–5 of 13